Financial Performance Quarter 2 (F45) (Reviewed) (Revised)

14 Aug 2025

Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025

Financial Performance Quarter 2 (F45) (Reviewed)

Financial Statement Quarter 2/2025 (Reviewed)

Report on the results of the Exercise of CGH-W5 (F53-5)

Notification the exercise of CGH-W5

Financial Statement Quarter 1/2025 (Reviewed) (Revised)

Financial Performance Quarter 1 (F45) (Reviewed) (Revised)

Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025

Financial Performance Quarter 1 (F45) (Reviewed)

Financial Statement Quarter 1/2025 (Reviewed)

Appointment of the Chairman of Audit Committee (F24-1)

Publication of the Minutes of the 2025 Annual General Meeting of Shareholders on the Company's Website

Appointment of Independent Director

Shareholders meeting's resolution

Publication of the Invitation to the 2025 Annual General Meeting of Shareholders on the Company's Website

Resolutions of BOD's Meeting, the omission of dividend payment, EBT from a Subsidiary, amendment of the company's objectives, amendment of the AOA, cancel the ESOP Options of a Subsidiary, and specified the date of AGM 2025 (Revised Template)

Financial Performance Yearly (F45) (Audited) (Revised)

Management Discussion and Analysis Yearly Ending 31 Dec 2024

Financial Performance Yearly (F45) (Audited)